Minnesota biotech firm Vyriad raises $29.5 million for cancer-fighting viruses
May 17, 2022 at 16:33 PM EDT
Vyriad Inc., a company that's engineering cancer-killing viruses, announced Tuesday it raised $29.5 million in Series B funding.
Photography by Christophe Tomatis